Innovation for Life

Developing Innovative drugs, Biosimilars, Platforms, and Diagnostic technologies to improve lives.

Advancing Antibody Science

Advancing antibody drugs and biosimilars to address unmet medical needs.

Creating Value for a Healthier Life

Improving patient access through cost-effective, high-quality biosimilars.

PRESTIGE BIOPHARMA

PRESTIGE BIOPHARMA IDC

PRESTIGE BIOLOGICS

7

Beyond technological discovery, expanding access to care for patients around the world

Innovative Drug

Development of First-in-Class therapeutics for unmet diseases

Biosimilar

Prominent Biosimilars pipelines for accelerating market access

Platform Technology

A drug delivery platform that enhances treatment convenience

Diagnostics

Diagnostics for Pancreatic cancer by detecting PAUF

Prestige News

Total 70
Number Thumbnail Title Author Date Votes Views
50 Prestige Biopharma IDC Files Patent for Bispecific Antibody Targeting Cytokine Storm–Related Inflammatory Diseases
김** | 2026.02.24 | Votes 0 | Views 1280
김** 2026.02.24 0 1280
49 Prestige Biopharma IDC Obtains ISO 9001 Certification for Global Quality Management System
김** | 2026.01.29 | Votes 0 | Views 1112
김** 2026.01.29 0 1112
48 Prestige Biopharma IDC Files Patent for PBP1710 Targeting Fibrotic Diseases
김** | 2026.01.23 | Votes 0 | Views 1183
김** 2026.01.23 0 1183
47 Prestige Biopharma Secures U.S. Patent for Novel Anticancer Antibody PBP1710
김** | 2025.12.08 | Votes 0 | Views 1192
김** 2025.12.08 0 1192
46 Prestige Biopharma IDC Selected for National Drug Development Project for TNBC Program
김** | 2025.11.25 | Votes 0 | Views 1353
김** 2025.11.25 0 1353
45 Prestige Biopharma Secures Herceptin Biosimilar Supply Deal in South America
김** | 2025.11.24 | Votes 0 | Views 1311
김** 2025.11.24 0 1311
44 Busan Mayor Visits Prestige Biopharma IDC to Support Regional Bioindustry Growth
김** | 2025.11.05 | Votes 0 | Views 940
김** 2025.11.05 0 940
43 Prestige Biopharma Presents PAUF-Based Pancreatic Cancer Program at ESMO 2025
we******** | 2025.10.21 | Votes 0 | Views 999
we******** 2025.10.21 0 999
42 Prestige Biopharma IDC Files Patent for Sustained-Release Subcutaneous Delivery Platform for High-Concentration Protein Therape
김** | 2025.10.14 | Votes 0 | Views 1074
김** 2025.10.14 0 1074
41 Prestige Biopharma IDC Publishes IHC-Based PAUF Diagnostic Platform Study in International Journal
we******** | 2025.09.17 | Votes 0 | Views 919
we******** 2025.09.17 0 919

Read Prestige news >>